Compare AOMR & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOMR | INFU |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.5M | 197.0M |
| IPO Year | 2019 | 2005 |
| Metric | AOMR | INFU |
|---|---|---|
| Price | $8.28 | $12.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $11.08 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 137.0K | 116.6K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 14.18% | N/A |
| EPS Growth | 53.85 | ★ 181.82 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | N/A | $3.20 |
| Revenue Next Year | $1.38 | $7.31 |
| P/E Ratio | ★ N/A | $60.70 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $7.96 | $7.29 |
| 52 Week High | $10.14 | $12.97 |
| Indicator | AOMR | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 41.96 | 61.08 |
| Support Level | $8.09 | $11.79 |
| Resistance Level | $8.53 | $12.97 |
| Average True Range (ATR) | 0.19 | 0.29 |
| MACD | -0.03 | -0.10 |
| Stochastic Oscillator | 23.75 | 45.07 |
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in first and second lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rate and credit cycles. The company operates in a single operating segment, which is to acquire, invest in, and finance mortgage-related assets.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.